Answers are grounded in this paper and cite their sources.
This study examines the association between the triglyceride-glucose (TyG) index and trabecular bone score (TBS) among US adults. In this cross-sectional analysis of National Health and Nutrition Examination Survey 2005 to 2008, the descriptive cohort included 3880 adults with TBS and fasting laboratory data; 3571 with positive fasting-subsample weights contributed to survey-weighted regression. TyG was calculated as ln(triglycerides [mg/dL] × glucose [mg/dL]/2) and is dimensionless. Covariate missingness was handled by multiple imputation. The primary model excluded bone mineral density (BMD) to avoid overadjustment; BMD-adjusted, complete-case, and renal-function sensitivity models were fitted. In the primary model, higher TyG was associated with lower TBS (β per 1-unit increase = −0.0097; 95% confidence interval = −0.0182 to −0.0012; P = .026). Restricted cubic spline showed nonlinearity ( P -overall < .001; P -nonlinear < .001). Notably, across TyG quartiles, spine BMD remained stable ( P = .104), whereas TBS declined substantially (from 1.446 to 1.310, P < .001), suggesting TyG specifically associates with bone quality rather than quantity. An exploratory two-segment knot at TyG 8.58 requires validation and is not a clinical threshold. Higher TyG is modestly associated with lower TBS, independent of BMD. While causal inference is precluded by cross-sectional design, TyG – calculated from routine labs at no extra cost – may serve as a pragmatic signal to prompt TBS evaluation in metabolically unhealthy patients, particularly obese males, even when BMD is normal. Longitudinal validation is needed.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: